Tango Therapeutics Inc (NASDAQ: TNGX) on Friday, soared 7.03% from the previous trading day, before settling in for the closing price of $7.97. Within the past 52 weeks, TNGX’s price has moved between $1.03 and $8.19.
Annual sales at Healthcare sector company grew by 7.47% over the past five years. The company achieved an average annual earnings per share of 7.66%. With a float of $63.83 million, this company’s outstanding shares have now reached $110.87 million.
Tango Therapeutics Inc (TNGX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tango Therapeutics Inc is 40.37%, while institutional ownership is 73.25%. The most recent insider transaction that took place on Sep 25 ’25, was worth 3,900,000. Before that another transaction happened on Sep 16 ’25, when Company’s 10% Owner sold 363,541 for $7.04, making the entire transaction worth $2,559,329. This insider now owns 14,363,975 shares in total.
Tango Therapeutics Inc (TNGX) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.27 earnings per share (EPS) for the period topping the consensus outlook (set at -0.37) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.66% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -8.69% during the next five years compared to 7.47% growth over the previous five years of trading.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
Tango Therapeutics Inc (TNGX) is currently performing well based on its current performance indicators. A quick ratio of 4.75 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 39.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.33, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Tango Therapeutics Inc (NASDAQ: TNGX) saw its 5-day average volume 2.32 million, a positive change from its year-to-date volume of 1.82 million. As of the previous 9 days, the stock’s Stochastic %D was 90.57%.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 99.60%, which indicates a significant increase from 98.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.54 in the past 14 days, which was higher than the 0.49 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.90, while its 200-day Moving Average is $3.83. Nevertheless, the first resistance level for the watch stands at $8.76 in the near term. At $9.00, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.43. If the price goes on to break the first support level at $8.09, it is likely to go to the next support level at $7.66. The third support level lies at $7.42 if the price breaches the second support level.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
Market capitalization of the company is 949.05 million based on 111,260K outstanding shares. Right now, sales total 42,070 K and income totals -130,300 K. The company made 3,180 K in profit during its latest quarter, and -38,850 K in sales during its previous quarter.
